Ironwood pharmaceuticals news

Author: zvwj

August undefined, 2024

WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics... WebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate the role of COO, and Rickard's ...

Home - Ironwood Pharmaceuticals

WebIronwood Pharmaceuticals to Participate in Upcoming Investor Conferences BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that management will participate in the following investor conferences: Cowen 43rd Annual Health Care Conference on Monday, March 6, 2024 at … WebJan 9, 2024 · Ironwood Pharmaceuticals Provides Update on FY 2024 Financial Guidance and Announces FY 2024 Financial Guidance – sNDA submitted to U.S. FDA in December … tyhis dickens

Ironwood Pharmaceuticals - Overview, News & Competitors

WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC. WebApr 11, 2024 · Ironwood Pharmaceuticals - IRWD News Today $10.52 +0.10 (+0.96%) (As of 03/31/2024 06:55 PM ET) Compare Today's Range $10.43 $10.62 50-Day Range $10.37 … WebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate … tams hiv

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results …

Ironwood Pharmaceuticals : Astellas and Ironwood Report …

WebJan 4, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and … WebIronwood Pharmaceuticals Non-GAAP EPS of $0.28 beats by $0.01, revenue of $108.64M misses by $1.76M, reaffirms FY guidance. Markets Insider Automation 54d. Ironwood Pharmaceuticals A earnings ... tam short story legacy pdfWebJan 9, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below … tamshi hosting

"WebMay 6, 2024 · BOSTON-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that its Board of Directors has authorized a new share repurchase program under which the Company may repurchase up to $150 million of its outstanding shares of common stock through December 2024. " - Ironwood pharmaceuticals news

Ironwood pharmaceuticals news

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by …

Web2 days ago · Ironwood Pharmaceuticals IRWD rose 3.4% amid speculation about an activist investor in the gastro intestinal drug company.; Gordon Haskett in a note on Thursday … WebApr 15, 2024 · As a group, sell-side analysts forecast that Ironwood Pharmaceuticals, Inc. will post 1.06 earnings per share for the current fiscal year. Insider Transactions at Ironwood Pharmaceuticals. In other news, CEO Thomas A. Mccourt sold 46,129 shares of the business’s stock in a transaction that occurred on Monday, March 27th. The stock was …

Did you know?

WebGreat news for Ford and Canadian Automotive industry! ... Director at Ironwood Pharmaceuticals Greater Boston. Lara Lane Nursing Student seeking RN Position Tampa, … Web1 day ago · BOSTON-- (BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its second quarter 2024 results and recent business performance. “We made progre... 8 months ago - Business Wire Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

WebApr 14, 2024 · Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23... WebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ...

WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics... WebApr 14, 2024 · In other Ironwood Pharmaceuticals news, COO Jason Rickard sold 16,746 shares of the stock in a transaction on Monday, February 27th. The shares were sold at an average price of $11.41, for a total ...

WebApr 11, 2024 · On April 10, 2024, Ironwood Pharmaceuticals, Inc. determined to eliminate the role of chief operating officer to streamline the executive leadership team. Accordingly, Jason Rickard's last day as Senior Vice President, Chief Operating Officer, and as an employee of the Company, will be May 12, 2024.

WebApr 14, 2024 · Ironwood Pharmaceuticals has a one year low of $9.73 and a one year high of $12.66. Ironwood Pharmaceuticals ( NASDAQ:IRWD – Get Rating) last announced its … tyhnbghbWebIronwood Pharmaceuticals 27,221 followers 1d Edited Our Director of Research Quality Assurance, Cheryl McCarthy, CQA, CBA, RQAP-GCP will be giving the President’s speech as well as chairing the... tamsin alexanderWebFeb 13, 2024 · BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for LINZESS ® (linaclotide) for the treatment of children and adolescents ages 6 … tyhm bts youtube